Tempest Therapeutics, Inc. (TPST)
3.20
+0.09
(+2.89%)
USD |
NASDAQ |
Dec 09, 16:00
3.20
0.00 (0.00%)
After-Hours: 16:51
Tempest Therapeutics Market Cap: 11.78M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 19.88M |
| AIM ImmunoTech, Inc. | 1.123M |
| IGC Pharma, Inc. | 27.77M |
| NovaBay Pharmaceuticals, Inc. | 229.34M |
| Protalix Biotherapeutics, Inc. | 140.34M |
Market Cap Related Metrics
| PEG Ratio | -0.0006 |
| Price to Book Value | 1.857 |
| Price | 3.20 |
| Earnings Yield | -315.7% |
| PEGY Ratio | -0.0006 |